from The Epoch Times: Clinical trials indicate success but there are risks and many unknowns in the novel therapy Patients needing a fecal microbiota transplant for recurrent Clostridioides difficile (C. diff) infections now have the option of getting stool in pill form. The U.S. Food and Drug Administration (FDA) recently approved Vowst, the first oral biologic […]
Source